Search

for
Search:

Sort by

Research

720-750 / 1000+ results

research SHPro ^® (mixture of Angelica gigas and Astragalus membranaceus ) in men with lower urinary tract symptoms: A randomized, double-blind, placebo-controlled clinical trial

January 2025 in “Investigative and Clinical Urology”

SHPro® improved urinary symptoms and erectile function in men and is safe.

research Faculty Opinions recommendation of Association between 5-alpha reductase inhibition and risk of hip fracture.

October 2008 in “Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature”

5-alpha reductase inhibitors do not increase hip fracture risk.

research Cutting Costs, Not Care: New Models for Affordable Men’s Health Medications

November 2025 in “Urology”

CPDC offers significant cost savings on men's health medications compared to Medicare and GoodRx.

research Drug-induced erectile dysfunction: a real-world pharmacovigilance study using the FDA adverse event reporting system database

1 citations , August 2024 in “Expert Opinion on Drug Safety”

Finasteride is most linked to drug-induced erectile dysfunction.

research 1194: The Long Term Effects of Doxazosin, Finasteride, and the Combination on Sexual Function in Men Participating in the MTOPS Study

8 citations , April 2004 in “The Journal of Urology”

Doxazosin and finasteride negatively affect sexual function in men with BPH.

research Valproate-Associated Transaminitis and Rhabdomyolysis

2 citations , April 2023 in “Curēus”

Valproic acid can cause muscle damage and liver issues, which improve after stopping the drug.

research Psoriatic Alopecia and Paradoxical Psoriasis Induced by Adalimumab Successfully Treated with Certolizumab: Clinical, Trichoscopic, and in vivo Reflectance Confocal Microscopy Features

7 citations , December 2022 in “Skin Appendage Disorders”

Certolizumab effectively treats psoriasis and psoriatic arthritis with fewer side effects than adalimumab.

research Cyproterone Acetate in the Treatment of Sexual Disorders: Pharmacological Base and Clinical Experience

30 citations , July 2009 in “Experimental and clinical endocrinology & diabetes”

Cyproterone acetate effectively treats sexual disorders by reducing sexual functions and is generally well-tolerated.

research Lupus and Pulmonary Nodules Consistent With Bronchiolitis Obliterans Organizing Pneumonia Induced by Carbamazepine

24 citations , December 1997 in “Mayo Clinic proceedings”

Carbamazepine may cause lung problems and lupus-like symptoms, which can improve after stopping the drug.

research Review: Dutasteride, fesoterodine, and finasteride are beneficial for lower urinary tract symptoms in older patients

October 2015 in “Annals of Internal Medicine”

Dutasteride, fesoterodine, and finasteride help older patients with urinary issues.

Depression Management And Prevention Program Through Apolipoprotein A And B Screening In The Elderly

research Program Pengelolaan Dan Pencegahan Depresi Melalui Pemeriksaan Apolipoprotein A Dan B Pada Kelompok Lanjut Usia

July 2024 in “jurnal ABDIMAS Indonesia”

Early detection of apolipoprotein levels helps reduce depression risk in the elderly.

research Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation

71 citations , November 2012 in “Expert Opinion on Drug Safety”

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

research Comparison of Different Alpha-blocker Combinations in Male Hypertensives with Refractory Lower Urinary Tract Symptoms

8 citations , January 2011 in “Korean Journal of Andrology”

The doxazosin plus tamsulosin combination improved symptoms effectively with fewer side effects.

research Dutasteride Improves Nocturia but Does Not Lead to Better Sleep: Results from the REDUCE Clinical Trial

3 citations , February 2021 in “The Journal of Urology”

Dutasteride can reduce night-time urination but it doesn't improve sleep quality.

research Terazosin reduced BPH symptoms and finasteride did not

1 citations , January 1997 in “ACP journal club”

research Role of Dutasteride in the Treatment of Androgenetic Alopecia

May 2024 in “Deleted Journal”

Dutasteride effectively treats hair loss in men who don't respond to finasteride.

research Possible involvement of 5α-reduced neurosteroids in adrenergic and serotonergic stimulation of GFAP gene expression in rat C6 glioma cells

17 citations , April 2006 in “Brain Research”

5α-reduced neurosteroids may help regulate glial cell differentiation.

research Off-label prescriptions: patient safety first

4 citations , August 2011 in “The Lancet Oncology”

Off-label drug use can be risky and requires careful consideration to ensure patient safety.

research Phosphodiesterase inhibitors used in androgenic alopecia as a possible risk factor for testicular tumor

April 2023 in “Medicina Clínica (english Edition)”

research Les Visiteurs des malades

November 2011 in “Nature Clinical Practice Urology”

5ARIs effectively treat and manage BPH by reducing prostate size and symptoms.

research A phase 2a study investigating the effects of ritlecitinib on brainstem auditory evoked potentials and intraepidermal nerve fiber histology in adults with alopecia areata

4 citations , July 2024 in “Pharmacology Research & Perspectives”

Ritlecitinib is safe and may effectively treat alopecia areata.

Long-Term Control of Epileptic Drop Attacks With the Combination of Valproate, Lamotrigine, and a Benzodiazepine: A Proof of Concept, Open Label Study

research Long-term control of epileptic drop attacks with the combination of valproate, lamotrigine, and a benzodiazepine: A ‘proof of concept,’ open label study

21 citations , April 2011 in “Epilepsia”

The drug combination significantly reduced epileptic drop attacks in patients.

research Pharmacokinetic Interaction between Finasteride and Terazosin, but not Finasteride and Doxazosin

6 citations , November 1998 in “The Journal of Clinical Pharmacology”

Finasteride interacts with terazosin, but not doxazosin; caution needed.

research A Patient Preference-Weighted Quantitative Benefit-Risk Analysis of Ritlecitinib for Alopecia Areata to Inform Medical Decision Making

September 2025 in “Value in Health”

research Finasteride < Rec INN; BAN; USAN >

5 citations , January 1991 in “Drugs of The Future”

A New Look at the 5-Alpha-Reductase Inhibitor Finasteride

research A New Look at the 5?-Reductase Inhibitor Finasteride

137 citations , March 2006 in “Cns Drug Reviews”

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

research 5-Alpha-Reductase Inhibitors and Combination Therapy

15 citations , July 2016 in “Urologic Clinics of North America”

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

research HAIR LOSS ASSOCIATED WITH ESCITALOPRAM: DO SSRIs AFFECT MELATONIN AT THE HAIR FOLLICLE?

June 2021 in “Psychiatria Danubina”

The antidepressant escitalopram likely caused hair loss in a patient.

research Alopecia areata with comorbid depression: early resolution with combined paroxetine–triamcinolone treatment

11 citations , May 2006 in “Journal of the European Academy of Dermatology and Venereology”

Combining paroxetine and triamcinolone effectively treats both alopecia areata and depression.

research A comparison of the effects of lamotrigine and levetiracetamand lamotrigine and valproate sodium in patients with epilepsy

January 2016

Levetiracetam and valproate sodium both reduce seizures when added to lamotrigine, but levetiracetam has fewer side effects.

← Previous page Next page →